Ardent Health, Inc. ARDT
10.54
0.06
0.57%
as of 25 Sep
- Market cap
- $1.5B
- P/E
- 19.2×
Follow ARDT
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | |
|---|---|---|---|---|---|
P/E ratio |
9.10 | 9.97 | 11.06 | 11.06 | 11.06 |
P/S ratio |
0.20 | 0.38 | 0.36 | 0.36 | 0.36 |
P/FCF ratio |
4.81 | 17.74 | 17.36 | 17.36 | 17.36 |
P/Operating CF |
5.56 | 18.92 | 16.82 | 16.82 | 16.82 |
P/B ratio |
0.74 | 1.49 | 1.75 | 1.75 | 1.75 |
Price to Tangible BV |
1.73 | 3.82 | 8.80 | 8.80 | 8.80 |
EV/Sales |
0.26 | 0.47 | 0.49 | 0.49 | 0.49 |
EV/EBITDA |
3.36 | 5.02 | 6.32 | 6.32 | 6.32 |
EV/Operating CF |
3.47 | 8.89 | 10.63 | 10.63 | 10.63 |
EV/FCF |
6.31 | 21.96 | 23.86 | 23.86 | 23.86 |
Quick Ratio |
1.33 | 1.37 | 1.22 | 1.31 | — |
Current Ratio |
1.97 | 1.94 | 1.63 | 1.74 | — |
Net Debt/EBITDA |
0.80 | 0.97 | 2.02 | 2.00 | 0.00 |
Debt/Assets |
20.78% | 22.10% | 25.08% | 26.30% | 0.00% |
Debt/Equity |
0.65 | 0.72 | 1.10 | 1.13 | 0.00 |
Asset Turnover |
1.23 | 1.23 | 1.17 | 2.29 | 0.00 |
Operating CF/Net income |
3.46 | 1.50 | 4.11 | (0.20) | 0.95 |
Capex/Depreciation |
(1.32) | (1.24) | (0.94) | (1.05) | (0.94) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 8.47% | 16.20% | 5.10% | 0.00% | 0.00% | |
| 2.65% | 4.34% | 1.17% | 8.44% | 0.00% | |
ROIC |
9.80% | 12.31% | 7.68% | 7.70% | 0.00% |
Return on Tangible Assets |
6.97% | 12.02% | 3.76% | 13.60% | 0.00% |
Average Days of Receivables |
39.60 | 45.46 | 52.32 | 42.93 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
78.00% | 78.19% | 80.56% | 79.99% | 78.83% |
Intangible Assets out of Total Assets |
0.18 | 0.19 | 0.19 | 0.21 | 0.00 |
Share Based Compensation of Revenue |
0.62% | 0.30% | 0.02% | 0.01% | 0.01% |
Graham Net Nets |
(1.24) | (0.71) | (0.96) | (0.96) | (0.96) |
Graham Number |
16.17 | 21.04 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
10.99% | 10.03% | 9.04% | 9.04% | 9.04% |
Free Cash Flow Yield |
20.81% | 5.64% | 5.76% | 5.76% | 5.76% |
Revenue per Share |
44.93 | 45.05 | 42.89 | 40.67 | 0.00 |
Operating CF per Share |
3.34 | 2.38 | 1.76 | (0.30) | 0.00 |
Capex per Share |
(1.51) | (1.42) | (1.09) | (1.20) | 0.00 |
Free Cash Flow per Share |
1.84 | 0.96 | 0.67 | (1.50) | 0.00 |
Cash per Share |
5.04 | 4.20 | 3.47 | 3.62 | — |
Shareholders Equity per Share |
11.98 | 11.49 | 8.52 | 8.24 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
11.98 | 11.49 | 8.52 | 8.24 | 0.00 |
Free Cash Flow |
258.61 | 127.52 | 84.29 | (189.47) | 11.46 |
Working Capital |
1,012.28 | 887.33 | 623.98 | 600.65 | — |
Capital Expenditures |
(211.90) | (187.51) | (137.41) | (151.11) | (135.44) |
Net Current Asset Value |
(1,545.17) | (1,602.15) | (2,038.46) | (2,030.08) | 0.00 |
EV/EBIT |
5.01 | 6.90 | 8.47 | 8.47 | 8.47 |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Net Profit Margin |
2.15% | 3.53% | 1.00% | 3.68% | 3.17% |
Price to Operating Income |
3.82 | 5.57 | 6.16 | 6.16 | 6.16 |
| Other line items | |||||
Depreciation/Fixed assets |
0.17 | 0.18 | 0.18 | 0.18 | 0.00 |
Cash ROIC |
(13.31%) | (17.24%) | (21.83%) | (30.93%) | 0.00% |
Accounts Receivable Turnover |
8.85 | 7.86 | 7.85 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
714.57 | 759.24 | 689.41 | — | — |
Average Payables |
429.59 | 437.90 | 397.67 | — | — |
Average Inventory |
116.84 | 110.29 | 106.32 | — | — |
Average Assets |
5,123.15 | 4,843.83 | 4,605.20 | 2,239.42 | — |
Average Common Equity |
1,603.71 | 1,298.11 | 1,057.26 | — | — |
Columns are period end dates